AXGN vs DCTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AXGN Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Axogen, Inc. Common Stock (AXGN) driven by superior Valuation, Momentum & Technical, Options & Structure while DCTH counters with relative strength in Growth & Margin. Fundamentally, AXGN trades at 79.3x Forward P/E with -5.2% operating margin (+26.2% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, AXGN sits in BREAKOUT (12th %ile IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AXGN Revenue | DCTH Revenue | AXGN Op. Margin | DCTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $80M | N/A | -24.4% | N/A | AXGN |
| FY2019 | $110M | N/A | -29.4% | N/A | AXGN |
| FY2020 | $110M | N/A | -20.6% | N/A | AXGN |
| FY2021 | $130M | $0M | -20.0% | -690.0% | AXGN |
| FY2022 | $140M | $0M | -21.4% | -1245.1% | AXGN |
| FY2023 | $160M | $0M | -13.5% | -1849.0% | AXGN |
| FY2024 | $190M | $40M | -1.8% | -33.4% | AXGN |
| FY2025 | $230M | $90M | -3.5% | 0.8% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AXGN | DCTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.3B | $743.8M | Larger Scale | AXGN |
| Trailing P/E Ratio Valuation | 128.2x | 133.6x | Lower Multiple | AXGN |
| Forward P/E Ratio Valuation | 79.3x | N/M | Lower Multiple | AXGN |
| Revenue Growth (YoY) Growth | +26.2% | +70.7% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | -5.2% | 5.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | -12.0% | 6.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | -10.3% | 5.4% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 88% ($23โ$60) | 80% ($8โ$23) | Stronger Trend | AXGN |
| Beta / 30D Volatility Risk Regime | 1.28ฮฒ ยท 123% Vol | 1.63ฮฒ ยท 131% Vol | Lower Realized Risk | AXGN |
| Unified Institutional Score Composite Signal | 33.1 / 100 (SELL) | 35.9 / 100 (SELL) | Higher Composite | DCTH |